4//SEC Filing
Hayward James A 4
Accession 0001144204-18-047569
CIK 0000744452other
Filed
Aug 30, 8:00 PM ET
Accepted
Aug 31, 4:04 PM ET
Size
10.4 KB
Accession
0001144204-18-047569
Insider Transaction Report
Form 4
Hayward James A
DirectorChairman, CEO and President10% Owner
Transactions
- Award
Stock Option (right to buy)
2018-07-10+666,667→ 666,667 totalExercise: $3.51From: 2018-07-10Exp: 2021-07-10→ Common Stock (666,667 underlying) - Disposition to Issuer
Stock Option (right to buy)
2018-07-10−666,667→ 0 totalExercise: $3.51Exp: 2018-07-10→ Common Stock (666,667 underlying) - Award
Stock Option (right to buy)
2018-08-29+250,000→ 250,000 totalExercise: $1.19From: 2018-08-29Exp: 2028-08-28→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]The two reported transactions involve an amendment of an outstanding option to extend the expiration date of such option from July 10, 2018 to July 10, 2021, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on July 11, 2011 and provided for vesting (i) with respect to 25% of the underlying shares on the original date of grant and (ii) with respect to the remaining underlying shares, ratably each anniversary thereafter until fully vested on the second anniversary of the original date of grant.
Documents
Issuer
APPLIED DNA SCIENCES INC
CIK 0000744452
Entity typeother
Related Parties
1- filerCIK 0001357784
Filing Metadata
- Form type
- 4
- Filed
- Aug 30, 8:00 PM ET
- Accepted
- Aug 31, 4:04 PM ET
- Size
- 10.4 KB